The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer

Manel B. Hammouda,Amy E. Ford,Yuan Liu,Jennifer Y. Zhang,Manel Hammouda,Amy Ford,Jennifer Zhang
DOI: https://doi.org/10.3390/cells9040857
IF: 6
2020-04-02
Cells
Abstract:The c-Jun N-terminal kinases (JNKs), with its members JNK1, JNK2, and JNK3, is a subfamily of (MAPK) mitogen-activated protein kinases. JNK signaling regulates a wide range of cellular processes, including cell proliferation, differentiation, survival, apoptosis, and inflammation. Dysregulation of JNK pathway is associated with a wide range of immune disorders and cancer. Our objective is to provide a review of JNK proteins and their upstream regulators and downstream effector molecules in common skin disorders, including psoriasis, dermal fibrosis, scleroderma, basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma.
cell biology
What problem does this paper attempt to address?